COM:BEXIMCOPHARMA
Beximco Pharma
- Stock
Last Close
33.50
22/11 14:00
Market Cap
1.73M
Beta: -
Volume Today
516.64K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 1.40B - | 1.53B 8.79% | 1.95B 27.87% | 2.23B 13.94% | 2.53B 13.74% | 3.03B 19.77% | 3.51B 15.87% | 5.13B 45.89% | 5.12B 0.09% | 4.52B 11.69% | ||
depreciation and amortization | 68.91M - | 90.19M 30.87% | 84.95M 5.80% | 98.11M 15.48% | 845.91M 762.23% | 942.76M 11.45% | 1.11B 18.16% | 1.11B 0.02% | 370.24M 66.77% | 2.06B 456.53% | ||
deferred income tax | ||||||||||||
stock based compensation | ||||||||||||
change in working capital | -1.69B - | -1.50B 11.01% | -40.63M 97.29% | -652.68M 1,506.35% | -1.91B 192.55% | -734.17M 61.55% | ||||||
accounts receivables | -573.45M - | 29.51M 105.15% | 431.61M 1,362.70% | 352.25M 18.39% | -431.84M 222.59% | |||||||
inventory | -1.21B - | -927.40M 23.40% | -70.14M 92.44% | -1.08B 1,445.92% | -2.57B 136.57% | -1.83B 28.70% | ||||||
accounts payables | -352.25M - | 431.84M 222.59% | ||||||||||
other working capital | -475.85M - | 655.64M - | 1.09B 66.98% | |||||||||
other non cash items | -1.47B - | -1.62B 9.83% | -2.04B 26.00% | -2.32B 14.00% | 127.10M 105.47% | 484.60M 281.28% | 954.48M 96.96% | 434.06M 54.52% | 1.91B 339.90% | 233.98M 87.75% | ||
net cash provided by operating activities | 1.82B - | 2.96B 62.71% | 5.54B 87.25% | 6.02B 8.67% | 5.49B 8.80% | 6.08B 10.77% | ||||||
investments in property plant and equipment | -2.76B - | -2.84B 2.56% | -2.57B 9.37% | -3.13B 21.64% | -5.06B 61.84% | -4.55B 10.15% | -2.28B 49.94% | -2.56B 12.44% | -2.94B 14.90% | -2.71B 7.81% | -1.99B 26.43% | |
acquisitions net | -2.13B - | -4.77B - | ||||||||||
purchases of investments | -339.78M - | 106.92M - | ||||||||||
sales maturities of investments | 935.60M - | 552.46M 40.95% | 547.18M 0.96% | 16.03M 97.07% | 323.36M 1,916.91% | |||||||
other investing activites | 5.40M - | 558.97M 10,247.85% | 5.35M 99.04% | 23.49M 339.29% | -91.30M 488.73% | 19.03M 120.85% | 5.07M 73.34% | 33.77M 565.56% | 26.08M 22.78% | 93.01M 256.64% | -412.73M 543.75% | |
net cash used for investing activites | -3.10B - | -2.28B 26.55% | -1.63B 28.46% | -2.55B 56.56% | -6.62B 159.69% | -4.51B 31.88% | -1.95B 56.83% | -2.52B 29.68% | -7.68B 204.20% | -2.62B 65.92% | -2.41B 8.05% | |
debt repayment | -1.41B - | -1.00B 29.17% | -504.64M 49.56% | -1.76B - | -4.67B 165.07% | |||||||
common stock issued | 100 - | |||||||||||
common stock repurchased | 1.41B - | |||||||||||
dividends paid | -47.58K - | -350.85M 737,281.63% | -367.89M 4.86% | -193.15M 47.50% | -502.76M 160.29% | -505.35M 0.52% | -601.96M 19.12% | -578.35M 3.92% | -1.62B 180.64% | -1.57B 3.40% | -1.59B 1.15% | |
other financing activites | 1.01B - | 36.10M 96.43% | 86.41M 139.39% | 162.54M 88.09% | 5.41B 3,225.94% | 2.27B 57.97% | -1.97B 186.74% | -2.38B 20.52% | 4.24B 278.44% | -229.38M 105.41% | ||
net cash used provided by financing activities | 1.01B - | -314.76M 131.13% | -281.48M 10.57% | -30.62M 89.12% | 4.90B 16,114.82% | 1.77B 63.97% | -3.57B 302.25% | -3.46B 3.22% | 2.62B 175.62% | -3.56B 236.15% | -6.26B 75.81% | |
effect of forex changes on cash | 215.62K - | 1.97M 813.03% | 45.36M - | 59.81M 31.86% | 20.29M 66.09% | |||||||
net change in cash | 42.75M - | -373.49M 973.58% | -74.76M 79.98% | 53.91M 172.10% | 101.61M 88.50% | 216.76M 113.32% | 24.52M 88.69% | 40.45M 64.95% | 194.71M 381.36% | -32.99M 116.94% | -281.58M 753.59% | |
cash at beginning of period | 552.98M - | 595.73M 7.73% | 222.24M 62.69% | 221.12M 0.50% | 292.12M 32.11% | 393.74M 34.78% | 610.49M 55.05% | 635.02M 4.02% | 973.96M 53.38% | 1.17B 19.99% | 1.14B 2.82% | |
cash at end of period | 595.73M - | 222.24M 62.69% | 147.48M 33.64% | 275.03M 86.49% | 393.74M 43.16% | 610.49M 55.05% | 635.02M 4.02% | 675.47M 6.37% | 1.17B 73.02% | 1.14B 2.82% | 854.11M 24.79% | |
operating cash flow | 1.82B - | 2.96B 62.71% | 5.54B 87.25% | 6.02B 8.67% | 5.49B 8.80% | 6.08B 10.77% | ||||||
capital expenditure | -2.76B - | -2.84B 2.56% | -2.57B 9.37% | -3.13B 21.64% | -5.06B 61.84% | -4.55B 10.15% | -2.28B 49.94% | -2.56B 12.44% | -2.94B 14.90% | -2.71B 7.81% | -2.23B 17.54% | |
free cash flow | -2.76B - | -2.84B 2.56% | -2.57B 9.37% | -3.13B 21.64% | -3.24B 3.64% | -1.59B 51.06% | 3.27B 306.11% | 3.46B 6.05% | 2.55B 26.29% | 3.37B 32.14% | 6.13B 81.64% |
All numbers in GBP (except ratios and percentages)